This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Andreea Balan-Cohen
Vice President
Contact
AndreeaBalan-Cohen@d220149.comOverview
Andreea Balan-Cohen, PhD, joined 趣赢平台 in June 2021 as a Vice President for Behavioral Health and Health Policy, with a focus on health care and transformation. She is a nationally recognized health care economist with 14+ years of experience managing and leading complex quantitative health care projects for public and private sector clients. She has extensive expertise in a wide array of data analytics methods and their applications to health care policy and economic analysis. Her research focuses on value-based care, payment reform, health system and health plan financial performance, quality measurement, patient experience, economic valuation, and socioeconomic determinants of health. Balan-Cohen will lead in the areas of Centers for Medicare and Medicaid Services (CMS) model implementation and evaluation along with performance and quality measurement.
Education
- PhD, Economics, Harvard University
- BA, Economics (summa cum laude), Harvard University
-
Effect of antimicrobial administration on fecal microbiota of critically ill dogs: Dynamics of antimicrobial resistance over time
4,
Animal Microbiome
January 2022
J. Menard, R. Goggs, P. Mitchell, Y. Yang, S. Robbins, R.J. Franklin-Guild, A.J. Thachil, et al.
DOILink for: Effect of antimicrobial administration on fecal microbiota of critically ill dogs: Dynamics of antimicrobial resistance over time -
Growth of coordinated specialty care in the United States with changes in federal funding policies: 2014–2018
Psychiatric Services
January 2022
P. George, Shoma Ghose, H.H. Goldman, J. O'Brien, T.C. Daley, L.B. Dixon, Abram Rosenblatt
DOILink for: Growth of coordinated specialty care in the United States with changes in federal funding policies: 2014–2018 -
Multi-laboratory evaluation of the Illumina iSeq platform for whole genome sequencing of salmonella, escherichia coli and listeria
8,
Microbial Genomics
January 2022
P.K. Mitchell, L. Wang, B.J. Stanhope, B.D. Cronk, R. Anderson, S. Mohan, L. Zhou, et al.
DOILink for: Multi-laboratory evaluation of the Illumina iSeq platform for whole genome sequencing of salmonella, escherichia coli and listeria